New insights into the role of NF1 in cancer

Neoplasma

Volumn 60, Issue 3, 2013, Pages 233-239

  Sabova, L ^a   Kretova, M ^a   Luciakova, K ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cancer development and progression; NF1 (nuclear factor 1); Signaling pathways

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; NUCLEAR FACTOR I; TRANSFORMING GROWTH FACTOR BETA; NEUROFIBROMIN;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE GENOMIC HYBRIDIZATION; ENERGY METABOLISM; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE SILENCING; GLYCOSYLATION; HUMAN; LUNG SMALL CELL CANCER; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; METABOLISM;

HUMANS; NEOPLASMS; NEUROFIBROMIN 1; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84879368140     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2013_031     Document Type: Review

References (71)

1. NAGATA K, GUGGENHEIMER RA, ENOMOTO T, LICHY JH, HURWITZ J. Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex. Proc Natl Acad Sci U S A 1982; 79: 6438-42. http://dx.doi.org/10.1073/pnas.79.21.6438
2. NAGATA K, GUGGENHEIMER RA, HURWITZ J. Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA. Proc Natl Acad Sci U S A 1983; 80: 6177-81. http://dx.doi.org/10.1073/pnas.80.20.6177
3. GUGGENHEIMER RA, STILLMAN BW, NAGATA K, TAMANOI F, HURWITZ J. DNA sequences required for the in vitro replication of adenovirus DNA. Proc Natl Acad Sci U S A 1984; 81: 3069-73.
4. HENNIGHAUSEN L, SIEBENLIST U, DANNER D, LEDER P, RAWLINS D et al. High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature 1985; 314: 289-92. http://dx.doi.org/10.1038/314289a0
5. GRONOSTAJSKI RM, ADHYA S, NAGATA K, GUGGENHEIMER RA, HURWITZ J. Site-specific DNA binding of nuclear factor I: analyses of cellular binding sites. Mol Cell Biol 1985; 5: 964-71.
6. GRONOSTAJSKI RM. Analysis of nuclear factor I binding to DNA using degenerate oligonucleotides. Nucleic Acids Res 1986; 14: 9117-32. http://dx.doi.org/10.1093/nar/14.22.9117
7. MEISTERERNST M, ROGGE L, FOECKLER R, KARAGHIOSOFF M, WINNACKER EL. Structural and functional organization of a porcine gene coding for nuclear factor I. Biochemistry 1989; 28: 8191-200. http://dx.doi.org/10.1021/bi00446a034
8. SANTORO C, MERMOD N, ANDREWS PC, TJIAN R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 1988; 334: 218-24. http://dx.doi.org/10.1038/334218a0
9. PAONESSA G, GOUNARI F, FRANK R, CORTESE R. Purification of a NF1-like DNA-binding protein from rat liver and cloning of the corresponding cDNA. EMBO J 1988; 7: 3115-23.
10. INOUE T, TAMURA T, FURUICHI T, MIKOSHIBA K. Isolation of complementary DNAs encoding a cerebellum-enriched nuclear factor I family that activates transcription from the mouse myelin basic protein promoter. J Biol Chem 1990; 265: 19065-70.
11. GIL G, OSBORNE TF, GOLDSTEIN JL, BROWN MS. Purification of a protein doublet that binds to six TGG-containing sequences in the promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem 1988; 263: 19009-19.
12. MEISTERERNST M, ROGGE L, DONATH C, GANDER I, LOTTSPEICH F et al. Isolation and characterization of the porcine nuclear factor I (NFI) gene. FEBS Lett 1988; 236: 27-32. http://dx.doi.org/10.1016/0014-5793(88)80279-5
13. RUPP RA, KRUSE U, MULTHAUP G, GOBEL U, BEYREUTHER K et al. Chicken NFI/TGGCA proteins are encoded by at least three independent genes: NFI-A, NFI-B and NFI-C with homologues in mammalian genomes. Nucleic Acids Res 1990; 18: 2607-16. http://dx.doi.org/10.1093/nar/18.9.2607
14. FLETCHER CF, JENKINS NA, COPELAND NG, CHAUDHRY AZ, GRONOSTAJSKI RM. Exon structure of the nuclear factor I DNA-binding domain from C. elegans to mammals. Mamm Genome 1999; 10: 390-6. http://dx.doi.org/10.1007/s003359901008
15. ALTMANN H, WENDLER W, WINNACKER EL. Transcriptional activation by CTF proteins is mediated by a bipartite low proline domain. Proc Natl Acad Sci USA 1994; 91: 3901-5. http://dx.doi.org/10.1073/pnas.91.9.3901
16. MUKHOPADHYAY SS, WYSZOMIERSKI SL, GRONOSTAJSKI RM, ROSEN JM. Differential interactions of specific nuclear factor I isoforms with the glucocorticoid receptor and STAT 5 in the cooperative regulation of WAP gene transcription. Mol Cell Biol 2001; 21: 6859-69. http://dx.doi.org/10.1128/MCB.21.20.6859-6869.2001
17. SINGH SK, WILCZYNSKA KM, GRZYBOWSKI A, YESTER J, OSRAH B et al. The unique transcriptional activation domain of nuclear factor-I-X3 is critical to specifically induce marker gene expression in astrocytes. J Biol Chem 2011; 286: 7315-7326. http://dx.doi.org/10.1074/jbc.M110.152421
18. LI G, MARGUERON R, HU G, STOKES D, WANG YH et al. Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo. Mol Cell 2010; 38: 41-53. http://dx.doi.org/10.1016/j.molcel.2010.01.042
19. STEFANCSIK R, SARKAR S. Relationship between the DNA binding domains of SMAD and NFI/CTF transcription factors defines a new superfamily of genes. DNA Seq 2003; 14: 233-9. http://dx.doi.org/10.1080/1085566031000141126
20. BANDYOPADHYAY S, GRONOSTAJSKI RM. Identification of a conserved oxidation-sensitive cysteine residue in the NFI family of DNA-binding proteins. J Biol Chem 1994; 269: 29949-55.
21. CHAUDHRY AZ, LYONS GE, GRONOSTAJSKI RM. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. Dev Dyn 1997; 208: 313-25. http://dx.doi.org/10.1002/(SICI)1097-0177(199703)208:3<313::AID-AJA3>3.0.CO;2-L
22. DAS NEVES L, DUCHALA CS, TOLENTINO-SILVA F, HAXHIU MA, COLMENARES C et al. Disruption of the murine nuclear factor I-A gene (Nfia) results in perinatal lethality, hydrocephalus, and agenesis of the corpus callosum. Proc Natl Acad Sci U S A 1999; 96: 11946-51. http://dx.doi.org/10.1073/pnas.96.21.11946
23. STEELE-PERKINS G, Plachez C, BUTZ KG, YANG G, BACHURSKI CJ et al. The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol 2005; 25: 685-98. http://dx.doi.org/10.1128/MCB.25.2.685-698.2005
24. STEELE-PERKINS G, BUTZ KG, LYONS GE, ZEICHNERDAVID M, KIM HJ et al. Essential role for NFI-C/CTF transcription-replication factor in tooth root development. Mol Cell Biol 2003; 23: 1075-84. http://dx.doi.org/10.1128/MCB.23.3.1075-1084.2003
25. DRILLER K, PAGENSTECHER A, UHL M, OMRAN H, BERLIS A et al. Nuclear factor I X deficiency causes brain malformation and severe skeletal defects. Mol Cell Biol 2007; 27: 3855-67. http://dx.doi.org/10.1128/MCB.02293-06
26. GRONOSTAJSKI RM. Roles of the NFI/CTF gene family in transcription and development. Gene 2000; 249: 31-45. http://dx.doi.org/10.1016/S0378-1119(00)00140-2
27. HENG YH, BARRY G, RICHARDS LJ, PIPER M. Nuclear factor I genes regulate neuronal migration. Neurosignals 2012; 20: 159-67. http://dx.doi.org/10.1159/000330651
28. NILSSON J, HELOU K, KOVACS A, BENDAHL PO, BJURSELL G et al. Nuclear Janus-activated kinase 2/nuclear factor 1-C2 suppresses tumorigenesis and epithelial-to-mesenchymal transition by repressing Forkhead box F1. Cancer Res 2010; 70: 2020-9. http://dx.doi.org/10.1158/0008-5472.CAN-09-1677
29. MOREL Y, BAROUKI R. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J Biol Chem 1998; 273: 26969-76. http://dx.doi.org/10.1074/jbc.273.41.26969
30. NARVAEZ MJ, ANDERSON GR, PICKWELL GV, QUATTROCHI LC. Characterization of adjacent E-box and nuclear factor 1-like DNA binding sequence in the human CYP1A2 promoter. J Biochem Mol Toxicol 2005; 19: 78-86. http://dx.doi.org/10.1002/jbt.20063
31. LING G, HAUER CR, GRONOSTAJSKI RM, PENTECOST BT, DING X. Transcriptional regulation of rat CYP2A3 by nuclear factor 1: identification of a novel NFI-A isoform, and evidence for tissue-selective interaction of NFI with the CYP2A3 promoter in vivo. J Biol Chem 2004; 279: 27888-95. http://dx.doi.org/10.1074/jbc.M403705200
32. LUCIAKOVA K, BARATH P, POLIAKOVA D, PERSSON A, NELSON BD. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells: the role of nuclear factor-1. J Biol Chem 2003; 278: 30624-33. http://dx.doi.org/10.1074/jbc.M303530200
33. EECKHOUTE J, CARROLL JS, GEISTLINGER TR, TORRES-ARZAYUS MI, BROWN M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 2006; 20: 2513-26. http://dx.doi.org/10.1101/gad.1446006
34. NAKAMURA M, OKURA T, KITAMI Y, HIWADA K. Nuclear factor 1 is a negative regulator of gadd153 gene expression in vascular smooth muscle cells. Hypertension 2001; 37: 419-24. http://dx.doi.org/10.1161/01.HYP.37.2.419
35. FURLONG EE, REIN T, MARTIN F. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol 1996; 16: 5933-45.
36. OUELLET S, VIGNEAULT F, LESSARD M, LECLERC S, DROUIN R et al. Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res 2006; 34: 6472-87. http://dx.doi.org/10.1093/nar/gkl861
37. GAUSSIN A, MODLICH U, BAUCHE C, NIEDERLANDER NJ, SCHAMBACH A et al. CTF/NF1 transcription factors act as potent genetic insulators for integrating gene transfer vectors. Gene Ther 2012; 19: 15-24. http://dx.doi.org/10.1038/gt.2011.70
38. COOKE DW, LANE MD. The transcription factor nuclear factor I mediates repression of the GLUT4 promoter by insulin. J Biol Chem 1999; 274: 12917-24. http://dx.doi.org/10.1074/jbc.274.18.12917
39. BISGROVE DA, MONCKTON EA, PACKER M, GODBOUT R. Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines. J Biol Chem 2000; 275: 30668-76. http://dx.doi.org/10.1074/jbc.M003828200
40. BRUN M, COLES JE, MONCKTON EA, GLUBRECHT DD, BISGROVE D, GODBOUT R. Nuclear factor I regulates brain fatty acid-binding protein and glial fibrillary acidic protein gene expression in malignant glioma cell lines. J Mol Biol 2009; 391: 282-300. http://dx.doi.org/10.1016/j.jmb.2009.06.041
41. MATSUOKA S, BALLIF BA, SMOGORZEWSKA A, Mc-DONALD ER, III, HUROV KE et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316: 1160-6. http://dx.doi.org/10.1126/science.1140321
42. MUKHOPADHYAY SS, ROSEN JM. The C-terminal domain of the nuclear factor I-B2 isoform is glycosylated and transactivates the WAP gene in the JEG-3 cells. Biochem Biophys Res Commun 2007; 358: 770-6. http://dx.doi.org/10.1016/j.bbrc.2007.04.185
43. KANE R, MURTAGH J, FINLAY D, MARTI A, JAGGI R et al. Transcription factor NFIC undergoes N-glycosylation during early mammary gland involution. J Biol Chem 2002; 277: 25893-903. http://dx.doi.org/10.1074/jbc.M202469200
44. DUVAL C, GAUDREAULT M, VIGNEAULT F, TOUZELDESCHENES L, ROCHETTE PJ et al. Rescue of the transcription factors Sp1 and NFI in human skin keratinocytes through a feeder-layer-dependent suppression of the proteasome activity. J Mol Biol 2012; 418: 281-99. http://dx.doi.org/10.1016/j.jmb.2012.01.021
45. YANG SH, GALANIS A, WITTY J, SHARROCKS AD. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 2006; 25: 5083-93. http://dx.doi.org/10.1038/sj.emboj.7601383
46. ROSSI P, KARSENTY G, ROBERTS AB, ROCHE NS, SPORN MB et al. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 1988; 52: 405-14. http://dx.doi.org/10.1016/S0092-8674(88)80033-3
47. OHSHIMA T, SHIMOTOHNO K. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4. J Biol Chem 2003; 278: 50833-42. http://dx.doi.org/10.1074/jbc.M307533200
48. YU L, HEBERT MC, ZHANG YE. TGF-beta receptoractivated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 2002; 21: 3749-59. http://dx.doi.org/10.1093/emboj/cdf366
49. LUCIAKOVA K, KOLLAROVIC G, BARATH P, NELSON BD. Growth-dependent repression of human adenine nucleotide translocator-2 (ANT2) transcription: evidence for the participation of Smad and Sp family proteins in the NF1-dependent repressor complex. Biochem J 2008; 412: 123-30. http://dx.doi.org/10.1042/BJ20071440
50. LUCIAKOVA K, KOLLAROVIC G, KRETOVA M, SABOVA L, NELSON BD. TGF-beta signals the formation of a unique NF1/Smad4-dependent transcription repressorcomplex in human diploid fibroblasts. Biochem Biophys Res Commun 2011; 411: 648-53. http://dx.doi.org/10.1016/j.bbrc.2011.07.017
51. PLASARI G, CALABRESE A, DUSSERRE Y, GRONOSTAJSKI RM, McNAIR A et al. Nuclear factor I-C links platelet-derived growth factor and transforming growth factor beta1 signaling to skin wound healing progression. Mol Cell Biol 2009; 29: 6006-17. http://dx.doi.org/10.1128/MCB.01921-08
52. PLASARI G, EDELMANN S, HOGGER F, DUSSERRE Y, MERMOD N et al. Nuclear factor I-C regulates TGF-{beta}-dependent hair follicle cycling. J Biol Chem 2010; 285: 34115-25. http://dx.doi.org/10.1074/jbc.M110.120659
53. LEE DS, YOON WJ, CHO ES, KIM HJ, GRONOSTAJSKI RM et al. Crosstalk between nuclear factor I-C and transforming growth factor-beta1 signaling regulates odontoblast differentiation and homeostasis. PLoS One 2011; 6: e29160. http://dx.doi.org/10.1371/journal.pone.0029160
54. NILSSON J, BJURSELL G, KANNIUS-JANSON M. Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells. Mol Cell Biol 2006; 26: 5663-74. http://dx.doi.org/10.1128/MCB.02095-05
55. UDELHOVEN M, LEESER U, FREUDE S, HETTICH MM, LAUDES M et al. Identification of a region in the human IRS2 promoter essential for stress induced transcription depending on SP1, NFI binding and ERK activation in HepG2 cells. J Mol Endocrinol 2010; 44: 99-113. http://dx.doi.org/10.1677/JME-08-0182
56. URAMOTO H, IZUMI H, NAGATANI G, OHMORI H, NAGASUE N et al. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression. Biochem J 2003; 371: 301-10. http://dx.doi.org/10.1042/BJ20021646
57. NAYAK BK, DAS BR. Differential binding of nuclear proteins to the TP53 gene promoter in male breast tumour. Eur J Cancer 1997; 33: 1484-7. http://dx.doi.org/10.1016/S0959-8049(97)00164-0
58. SUN P, DONG P, DAI K, HANNON GJ, BEACH D. p53-independent role of MDM2 in TGF-beta1 resistance. Science 1998; 282: 2270-2. http://dx.doi.org/10.1126/science.282.5397.2270
59. JOHANSSON FK, BRODD J, EKLOF C, FERLETTA M, HESSELAGER G et al. Identification of candidate cancercausing genes in mouse brain tumors by retroviral tagging. Proc Natl Acad Sci U S A 2004; 101: 11334-7. http://dx.doi.org/10.1073/pnas.0402716101
60. SCRIDELI CA, CARLOTTI CG, JR., OKAMOTO OK, ANDRADE VS, CORTEZ MA et al. Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol 2008; 88: 281-91. http://dx.doi.org/10.1007/s11060-008-9579-4
61. SONG HR, GONZALES-GOMEZ I, SUH GS, COMMINS DL, SPOSTO R et al. Nuclear factor IA is expressed in astrocytomas and is associated with improved survival. Neuro Oncol 2010; 12: 122-32. http://dx.doi.org/10.1093/neuonc/nop044
62. MALIN D, KIM IM, BOETTICHER E, KALIN TV, RAMAKRISHNA S et al. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression. Mol Cell Biol 2007; 27: 2486-98. http://dx.doi.org/10.1128/MCB.01736-06
63. TOBIOKA H, ISOMURA H, KOKAI Y, TOKUNAGA Y, YAMAGUCHI J et al. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 2004; 35: 159-64. http://dx.doi.org/10.1016/j.humpath.2003.09.013
64. HAN W, JUNG EM, CHO J, LEE JW, HWANG KT et al. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer. Genes Chromosomes Cancer 2008; 47: 490-9. http://dx.doi.org/10.1002/gcc.20550
65. MOON HG, HWANG KT, KIM JA, KIM HS, LEE MJ et al. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol 2011; 5: 538-44. http://dx.doi.org/10.1016/j.molonc.2011.08.002
66. LANDREVILLE S, VIGNEAULT F, BERGERON MA, LECLERC S, GAUDREAULT M et al. Suppression of alpha5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigment Cell Melanoma Res 2011; 24: 643-55. http://dx.doi.org/10.1111/j.1755-148X.2011.00869.x
67. RATHINAM R, ALAHARI SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev 2010; 29: 223-37. http://dx.doi.org/10.1007/s10555-010-9211-x
68. ZHOU Z, FLESKEN-NIKITIN A, CORNEY DC, WANG W, GOODRICH DW et al. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Res 2006; 66: 7889-98. http://dx.doi.org/10.1158/0008-5472.CAN-06-0486
69. DOOLEY AL, WINSLOW MM, CHIANG DY, BANERJI S, STRANSKY N et al. Nuclear factor I/B is an oncogene in small cell lung cancer. Genes Dev 2011; 25: 1470-5. http://dx.doi.org/10.1101/gad.2046711
70. WISTUBA II, GAZDAR AF, MINNA JD. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001; 28: 3-13. http://dx.doi.org/10.1016/S0093-7754(01)90072-7
71. SCHUUR ER, KRUSE U, IACOVONI JS, VOGT PK. Nuclear factor I interferes with transformation induced by nuclear oncogenes. Cell Growth Differ 1995; 6: 219-27.